highly significantP < 0.001
We observed a 4.4-fold decrease in RANTES in HLXL-treated group, which was highly significant ( P < 0.001) when compared to the control group.
We observed a 4.4-fold decrease in RANTES in HLXL-treated group, which was highly significant ( P < 0.001) when compared to the control group.